Baxter International Inc (BAX)
31.96
+0.26
(+0.82%)
USD |
NYSE |
Nov 15, 16:00
32.04
+0.08
(+0.25%)
After-Hours: 20:00
Baxter International Research and Development Expense (TTM): 754.00M for Sept. 30, 2024
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| September 30, 2024 | 754.00M |
| June 30, 2024 | 758.00M |
| March 31, 2024 | 750.00M |
| December 31, 2023 | 738.00M |
| September 30, 2023 | 616.00M |
| June 30, 2023 | 634.00M |
| March 31, 2023 | 617.00M |
| December 31, 2022 | 603.00M |
| September 30, 2022 | 584.00M |
| June 30, 2022 | 562.00M |
| March 31, 2022 | 553.00M |
| December 31, 2021 | 531.00M |
| September 30, 2021 | 531.00M |
| June 30, 2021 | 525.00M |
| March 31, 2021 | 503.00M |
| December 31, 2020 | 521.00M |
| September 30, 2020 | 542.00M |
| June 30, 2020 | 563.00M |
| March 31, 2020 | 612.00M |
| December 31, 2019 | 595.00M |
| September 30, 2019 | 614.00M |
| June 30, 2019 | 636.00M |
| March 31, 2019 | 644.00M |
| December 31, 2018 | 655.00M |
| September 30, 2018 | 663.00M |
| Date | Value |
|---|---|
| June 30, 2018 | 647.00M |
| March 31, 2018 | 628.00M |
| December 31, 2017 | 615.00M |
| September 30, 2017 | 588.00M |
| June 30, 2017 | 597.00M |
| March 31, 2017 | 637.00M |
| December 31, 2016 | 646.00M |
| September 30, 2016 | 651.00M |
| June 30, 2016 | 640.00M |
| March 31, 2016 | 596.00M |
| December 31, 2015 | 603.00M |
| September 30, 2015 | 598.00M |
| June 30, 2015 | 599.00M |
| March 31, 2015 | 770.00M |
| December 31, 2014 | 936.00M |
| September 30, 2014 | 593.00M |
| June 30, 2014 | 721.00M |
| March 31, 2014 | 672.00M |
| December 31, 2013 | 609.00M |
| September 30, 2013 | 1.012B |
| June 30, 2013 | 1.025B |
| March 31, 2013 | 1.058B |
| December 31, 2012 | 1.081B |
| September 30, 2012 | 1.119B |
| June 30, 2012 | 1.068B |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
503.00M
Minimum
Mar 2021
758.00M
Maximum
Jun 2024
604.60M
Average
589.50M
Median
Research and Development Expense (TTM) Benchmarks
| Boston Scientific Corp | 1.519B |
| Haemonetics Corp | 60.10M |
| Accuray Inc | 47.84M |
| Masimo Corp | 183.10M |
| Insulet Corp | 201.00M |